MBF Bioscience’s New Software Vesselucida 360 Reconstructs Microvascular Networks in 3D
Williston, VT – September 5, 2018 – Researchers studying microvascular networks and vessels have a groundbreaking new software application to facilitate their work. Developed by MBF Bioscience, Vesselucida® 360 automatically reconstructs and analyzes microvascular networks in 3D.
Specifically designed to recognize the intricacies of the vascular system, Vesselucida features sophisticated algorithms that quickly and accurately create 3D reconstructions of images and tissue specimens. Built-in analyses provide data on segments and node counts, frequency of anastomoses, as well as metrics on vessel surface and volume.
Automatic reconstruction of vascular structure labeled with tomato lectin
Image courtesy Dr. Stan Watson, University of Michigan, USA
Vesselucida 360 also features a full suite of tools, which lets researchers manually trace and edit 3D reconstructions to fine-tune particularly complex image data. Companion analysis software, Vesselucida Explorer performs sophisticated data analysis for scientists seeking answers to their most challenging research questions.
“For the first time, researchers studying microvasculature and how it is affected by illnesses, injuries and treatments for those afflictions, have a tool specifically designed for these studies,” says Jack Glaser, President of MBF Bioscience. “We believe Vesselucida will have a significant impact in advancing scientific research in this field.”
For a comprehensive evaluation on how Vesselucida 360 can meet your research needs, we invite you to consult with one of our MBF Bioscience staff scientists.
Visit https://www.mbfbioscience.com/vesselucida360 for more information about Vesselucida 360.
About MBF Bioscience:
MBF Bioscience creates quantitative imaging and visualization software for stereology, neuron reconstruction, vascular analysis, c. elegans behavior analysis and medical education, integrated with the world’s leading microscope systems, to empower research. Our development team and staff scientists are actively engaged with leading bioscience researchers, constantly working to refine our products based on state-of-the-art scientific advances in the field.
Founded as MicroBrightField, Inc. in 1988, we changed our name to MBF Bioscience in 2005 to reflect the expansion of our products and services to new microscopy techniques in all fields of biological research and education. While we continue to specialize in neuroscience research, our products are also used extensively in the research fields of stem cells, lung, kidney, cardiac, cancer, and toxicology.
MBF Bioscience has grown into a global business, with offices in North America, Europe, Japan, and South Korea, and a dealer network active on five continents.
Our commitment to innovative products and unrivaled customer support has gained high praise from distinguished scientists who use our products all over the world. Our flagship products Stereo Investigator and Neurolucida are the most widely-used analysis systems for stereology and neuron reconstruction.
